Clinical Trials Logo

Clinical Trial Summary

The goal of this prospective observational cohort study is to learn about treatment strategies for unruptured intracranial aneurysms in the Chinese population. The main questions it aims to answer are: - To establish a cohort of patients with intracranial unruptured aneurysm and explore the optimal clinical treatment strategy. - To establish clinical management path for patients with unruptured intracranial aneurysm. According to the treatment of all patients with unruptured intracranial aneurysm, they were divided into the following groups: 1. Conservative treatment group; 2. Intracranial aneurysm clipping group; 3. Coil embolization or stent-assisted coil embolization group; 4. Flow diversion group.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05844163
Study type Observational [Patient Registry]
Source Beijing Tiantan Hospital
Contact Wang shuo, M.D.
Phone 13801180330
Email captain9858@126.com
Status Recruiting
Phase
Start date December 1, 2021
Completion date November 1, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT06238115 - Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair Phase 2/Phase 3
Completed NCT05355259 - ACtive Catheterization for EndovaScular TreatmentS N/A
Recruiting NCT05941377 - Enhanced Versus Standard Blood Pressure Lowering on Intracranial Aneurysm Rupture or Growth China Antihypertensive Trial for Intracranial Aneurysm (ChATIA-1) N/A
Completed NCT03989557 - Application of Platelet Function Test in Prevention of Ischemic Events After Stent Placement in Intracranial Aneurysms Phase 4
Recruiting NCT05491980 - Florida Cerebrovascular Disease Biorepository and Genomics Center
Recruiting NCT04578808 - Unruptured Cerebral Aneurysm: Prediction of Evolution